Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Squamous Cell Carcinoma of Oral Cavity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05980702
What this trial is testing

4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC

Who this might be right for
HNSCCOral CancerPD-1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 192
Testing effectiveness (Phase 2)Looking for participantsNCT05069857
What this trial is testing

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 46
Testing effectiveness (Phase 2)UnknownNCT03784066
What this trial is testing

Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Universitaire Ziekenhuizen KU Leuven 21
Testing effectiveness (Phase 2)Ended earlyNCT00017173
What this trial is testing

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 13
Large-scale testing (Phase 3)UnknownNCT00193843
What this trial is testing

Oral Cancer Adjuvant Therapy (OCAT) Trial

Who this might be right for
Mouth Neoplasms
Tata Memorial Hospital 900
Testing effectiveness (Phase 2)Looking for participantsNCT05098119
What this trial is testing

Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Early research (Phase 1)UnknownNCT03843515
What this trial is testing

Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Amsterdam UMC, location VUmc 17